AI-Rad Companion Brain MR is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Siemens Healthcare. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Annalise Enterprise is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Harrison-AI Medical Technologies. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
AZmed Rayvolve is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Behold Red Dot is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
BriefCase-Triage Care Multi-Triage CT is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Aidoc Medical. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Critical Care Suite 2.1 is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: GE Medical Systems Information Technologies. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Gleamer BoneView is a Phase 7 product-level candidate for international coverage. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
icometrix-ICH is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Icometrix. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
JLK-NCCT is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: JLK. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
Median LCS / eyonis LCS is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Median Technologies. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
qXR-Detect is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Qure.ai Technologies. Panel: Radiology. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
HealthAIdir